Coming from you who said management increased the dosage because they didn't see enough efficacy when on the same post mentioned the excellent CR result and then purposely cutting out the asterisk from 20 April 2024* which was on the same page you used to incorrectly calculate the low DRR and then make a disclaimer you need to see more data when you already made up your mind, very funny indeed.
Like I said, why don't you contact Tobias about your question with HER-Vaxx and the "poor" clinical trial data.
"Frontline vaccination with the B-cell peptide compound HER-Vaxx (IMU-131), combined with standard-of-care chemotherapy induces high levels of HER2-specific antibodies mediating ADCC and intracellular phosphorylation inhibition resulting in overall survival benefit in patients with HER2+ metastatic or advanced gastric/GEJ adenocarcinoma – Final results from Phase II/HERIZON study"
Why IMU is a multi multi bagger, page-25020
-
- There are more pages in this discussion • 783 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $396.8M | |||
| Open | High | Low | Value | Volume |
| 5.5¢ | 5.5¢ | 5.3¢ | $374.4K | 6.932M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 13 | 884300 | 5.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.4¢ | 759998 | 2 |
View Market Depth
| Last trade - 16.10pm 14/08/2024 (20 minute delay) ? |
| IMU (ASX) Chart |